Long-term effectiveness of a staged assessment for paediatric problematic severe asthma

Sharples James, Gupta Atul, Fleming Louise, Bossley Cara J., Bracken-King Marcella, Hall Pippa, Hayward Abigail, Puckey Michelle, Balfour-Lynn Ian M., Rosenthal M., Bush Andrew, Saglani Sejal

Source: Eur Respir J 2012; 40: 264-267
Journal Issue: July
Disease area: Airway diseases, Paediatric lung diseases

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Sharples James, Gupta Atul, Fleming Louise, Bossley Cara J., Bracken-King Marcella, Hall Pippa, Hayward Abigail, Puckey Michelle, Balfour-Lynn Ian M., Rosenthal M., Bush Andrew, Saglani Sejal. Long-term effectiveness of a staged assessment for paediatric problematic severe asthma. Eur Respir J 2012; 40: 264-267

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Role of a prolonged inpatient admission when evaluating children with problematic severe asthma
Source: Eur Respir J, 51 (2) 1701061; 10.1183/13993003.01061-2017
Year: 2018



The experience of long-term prognosis evaluation of childhood asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 164s
Year: 2005

Long-term benefits of pulmonary rehabilitation in patients with chronic asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 454s
Year: 2002

The use of omalizumab in the management of severe chronic paediatric asthma
Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma
Year: 2008


Long-term effects of multidisciplinary inpatient asthma treatment
Source: Virtual Congress 2021 – Paediatric allergic asthma: novel therapeutics and monitoring approaches
Year: 2021


Evaluation in a severe asthma expert center improves asthma outcomes.
Source: International Congress 2018 – New modalities in asthma treatment
Year: 2018



Accuracy in assessment of acute asthma needs improved to avoid potential adverse outcomes
Source: Annual Congress 2012 - Exacerbations of asthma and COPD: assessment, impact and novel treatments
Year: 2012


Long-term efficacy of QMF149 in persistent asthma
Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma
Year: 2012


Cost implications for the introduction of omalizumab in to the management of severe chronic asthma in children
Source: Eur Respir J 2006; 28: Suppl. 50, 481s
Year: 2006

Home-based individualized pulmonary rehabilitation: Clinical efficiency and relevance in severe COPD patients
Source: Annual Congress 2010 - Pulmonary rehabilitation: understanding and developing the intervention
Year: 2010

Long-term effectiveness of PEF-guided self-management in asthma
Source: Annual Congress 2007 - Novel issues in the treatment and control of asthma
Year: 2007


Long-term management of persistent asthma in adults
Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=376
Year: 2003

Long-term efficacy of 1 year anti-inflammatory treatment in paediatric patients with mild persistent asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 379s
Year: 2004

A digital therapy for proactively managing exacerbations and delivering therapeutic benefit to patients with moderate to severe asthma
Source: International Congress 2019 – Clinical approach to asthma management
Year: 2019

Analysis of two-year treatment with omalizumab patients with severe asthma in real clinical practice
Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma
Year: 2019


Evaluating the efficacy of omalizumab in severe persistent asthma patients
Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Year: 2017

Successful use of a ²bottom up² strategy to reduce acute asthma morbidity during childhood
Source: Eur Respir J 2006; 28: Suppl. 50, 481s
Year: 2006